Trial intelligence / Profile preview

Pioglitazone effects on Oxycodone abuse liability

NCT01395784Phase 2Completed

Sponsor
New York State Psychiatric Institute
Start
Aug 2010
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pioglitazone in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Aug 2010; status: completed.

02

Drugs

pioglitazone
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT01395784.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01395784.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call